Effect of Aromatherapy for Facial Aesthetics in Alleviating Signs of Aging: Pilot Study
Launched by UNIVERSITY OF SAO PAULO · Jul 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the effects of aromatherapy, specifically using geranium essential oil, on reducing signs of aging in women's facial skin. The study aims to see if applying a diluted form of this essential oil twice a day can help improve wrinkles, skin hydration, and elasticity. It involves 38 participants aged 45 to 55 who will be divided into two groups: one group will receive the geranium oil treatment, while the other group will use a placebo, which is a product without the active ingredient.
To be eligible for this study, participants must be cisgender women between 45 and 55 years old and show specific signs of aging on their skin. They should not have any serious health issues, be pregnant or breastfeeding, or have undergone certain cosmetic procedures recently. Participants will apply the treatment at home and will have their skin's condition measured using special equipment throughout the study. This trial is an opportunity for those looking for natural, non-invasive ways to address skin aging while being part of a scientific research project.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • cisgender women;
- • 45 to 55 years old;
- • classification of II and III on the Glogau Scale;
- • agree to participate in the research considering the conditions and stages of the study protocol;
- • do not present adverse reactions to the topical use of the essential oil and its carrier base.
- Exclusion Criteria:
- • pregnant women;
- • breastfeeding women;
- • people diagnosed with neurological, serious dermatological diseases and others serious illnesses;
- • people with facial injuries;
- • severe allergies or occurrence of serious adverse events due to the use of cosmetics and/or cosmeceuticals in the past;
- • participants who present an allergic reaction during the allergenicity test and/or during the study;
- • those who underwent aesthetic facial procedures with fillers (except lip fillers) and botulinum toxin up to 6 months before the start of the protocol, PDO threads up to 3 months before, and chemical, mechanical and laser peelings, as well as microneedling, up to 1 month before the beginning of participation;
- • use of cosmeceuticals seven to ten days before participating in the study, as well as during it, with only the use of photoprotector being permitted and recommended;
- • people who have undergone facial aesthetic surgery, except rhinoplasty.
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, , Brazil
Patients applied
Trial Officials
Amanda K S Vieira, Principal researcher
Principal Investigator
University of Sao Paulo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported